Atlas Trials

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

Clinical trial NCT01067053 · UNKNOWN

Trial details

NCT number
NCT01067053
Sponsor
Grupo Espanol Multidisciplinario del Cancer Digestivo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2009-11-01
Primary completion
2010-11-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.